We report the results of a collaborative study on malignant syndrome (MS) that developed in
patients being treated with levodopa and other anti-parkinsonian drugs. We analyzed …

We report a consensus statement of the collaborative research group on the prevention and
treatment of malignant syndrome (MS) in Parkinson's disease. The syndrome is quite similar …

We reviewed literature on malignant syndrome occurring in patients with Parkinson's
disease (PD) during the course of drug therapy. Clinical features were high fever, marked …

Introduction. We elucidated the cause and clinical characteristics of malignant syndrome
(MS) in patients with Parkinson's disease (PD), early-onset parkinsonism (EOP), and other …

A symptom complex identical to neuroleptic malignant syndrome (MS) is known to develop
in patients with idiopathic Parkinson's disease (PD) or other forms of parkinsonism on long …

A syndrome resembling the neuroleptic malignant syndrome (NMS) is known to develop
occasionally following interruption of dopaminergic medications in patients with Parkinson''s …

Neuroleptic malignant syndrome (NMS), a side effect that develops mainly during treatment
with anti psychotic agents, is associated with high fever, impaired consciousness …

A clinical picture named neuroleptic malignant-like syndrome has been described in
patients with Parkinson's disease (PD) who suddenly stop their l-dopa treatment. The …

Three cases of a syndrome resembling neuroleptic malignant syndrome are described in
patients never exposed to neuroleptics. Each patient had a long history of Parkinson's …

Abstract Haryugaoka Mental Hospital, Koriyama-shi. A 63-year-old woman with a diagnosis
of Parkinson's disease developed an unusual symptom complex which consisted of …